|
5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials
|
Feb 2012
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
|
Are T-cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes?
|
Feb 2012
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes: it is all in the genes.
|
Feb 2012
|
J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
|
A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes
|
Feb 2012
|
Mol Biosyst
|
myelodysplastic syndromes (MDS)
|
|
The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria
|
Feb 2012
|
Am J Hum Genet
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Bone marrow versus peripheral blood sibling transplants in acquired aplastic anemia: survival advantage for marrow in all age groups.
|
Feb 2012
|
Haematologica
|
aplastic anemia
|
|
Multicentre validation of a reproducible flow cytometric score for the diagnosis of low-risk myelodysplastic syndromes: results of a European LeukemiaNET study
|
Feb 2012
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells
|
Feb 2012
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
|
Feb 2012
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Antibodies in the treatment of aplastic anemia.
|
Feb 2012
|
Arch Immunol Ther Exp
|
aplastic anemia
|
